Phase III randomized multicenter of Melacine [melanoma vaccine] and IFN [interferon] vs IFN as adjuvant therapy for resected stage III melanoma
Phase of Trial: Phase III
Latest Information Update: 29 May 2007
At a glance
- Drugs Melanoma vaccine Melacine (Primary) ; Interferon alpha-2b; Interferon alpha-2b
- Indications Malignant melanoma
- Focus Registrational; Therapeutic Use
- 29 May 2007 Status changed from in progress to completed.
- 09 Jan 2006 New trial record.